Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Death from bronchial asthma.

E D Robin1

  • 1Stanford University Medical Center, CA 94305.

Chest
|March 1, 1988
PubMed
Summary
This summary is machine-generated.

US asthma mortality is rising across all age groups, contrasting with perceived treatment advances. This suggests potential iatrogenic causes requiring a re-evaluation of asthma management strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spring Books: 200 years at Harvard.

British medical journal (Clinical research ed.)·2010
Same author

The effect of different grades of penicillin on the motility of the rabbit uterus.

Federation proceedings·2010
Same author

The effect of urethane upon the erythrocyte membrane.

Federation proceedings·2010
Same author

A study of urinary gonadotropin output in patients with testicular tumor.

Federation proceedings·2010
Same author

Studies on the toxicity of para-aminobenzoic acid in rats.

Federation proceedings·2010
Same author

The fallacy of the Exton-Rose glucose tolerance test.

The American journal of the medical sciences·2010
Same journal

A Comparative Study of Radiation Exposure in Conventional and Robotic Bronchoscopy.

Chest·2026
Same journal

Independent Prognostic Contributions of Anti-Ro52 and Anti-MDA5 in Autoimmune-Associated Interstitial Lung Disease.

Chest·2026
Same journal

Lung aeration and gas exchange in SGA or AGA infants with moderate-severe BPD: secondary analysis of the PATH-BPD study.

Chest·2026
Same journal

Lung Cancer Incidence and Mortality after Negative Low-Dose CT Screening Results.

Chest·2026
Same journal

Symptom prevalence and impact on lung cancer risk in the SUMMIT study.

Chest·2026
Same journal

How I Do It: De-escalation of Prostacyclin-Based Therapy in Patients Treated With Sotatercept.

Chest·2026
See all related articles

Area of Science:

  • Pulmonology
  • Public Health
  • Epidemiology

Background:

  • Evidence indicates a progressive and significant increase in asthma-related mortality in the United States.
  • This rise in deaths is observed across all age demographics, with a more pronounced effect in older populations.
  • The observed mortality trend contrasts with the general perception of advancements in asthma treatment and management.

Purpose of the Study:

  • To investigate the increasing mortality rates associated with bronchial asthma in the US.
  • To explore potential causes for the rise in asthma deaths, considering both known and unknown factors.
  • To propose a framework for risk-benefit analysis to improve patient outcomes in asthma care.

Main Methods:

  • Analysis of epidemiological data on asthma mortality trends in the US.

Related Experiment Videos

  • Review of current medical perceptions and advancements in asthma management.
  • Application of risk-benefit analysis principles to identify potential iatrogenic contributions to mortality.

    • Main Results:

    • incontrovertible evidence of a striking increase in asthma mortality in the US.
    • Increased death rates are evident across all age groups, notably in older populations.
    • The exact causes remain unknown, but the trend is occurring despite perceived therapeutic advances.

    Conclusions:

    • The escalating asthma mortality warrants urgent attention and investigation.
    • A prudent approach involves considering iatrogenic factors as a potential cause for excess deaths.
    • Re-evaluating asthma management through a risk-benefit lens may improve patient outcomes and mitigate mortality.